Freimut H. Schilling

2.4k total citations
50 papers, 1.5k citations indexed

About

Freimut H. Schilling is a scholar working on Neurology, Molecular Biology and Cancer Research. According to data from OpenAlex, Freimut H. Schilling has authored 50 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Neurology, 15 papers in Molecular Biology and 11 papers in Cancer Research. Recurrent topics in Freimut H. Schilling's work include Neuroblastoma Research and Treatments (27 papers), Cancer, Hypoxia, and Metabolism (11 papers) and Cancer therapeutics and mechanisms (9 papers). Freimut H. Schilling is often cited by papers focused on Neuroblastoma Research and Treatments (27 papers), Cancer, Hypoxia, and Metabolism (11 papers) and Cancer therapeutics and mechanisms (9 papers). Freimut H. Schilling collaborates with scholars based in Germany, Switzerland and Sweden. Freimut H. Schilling's co-authors include Frank Berthold, Barbara Hero, Thorsten Simon, R. Erttmann, J. Treuner, Claudia Spix, Bernhard Kremens, Thomas Klingebiel, Johannes Sander and K. Schwarz and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Freimut H. Schilling

47 papers receiving 1.5k citations

Peers

Countries citing papers authored by Freimut H. Schilling

Since Specialization

Citations

This map shows the geographic impact of Freimut H. Schilling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Freimut H. Schilling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Freimut H. Schilling more than expected).

Fields of papers citing papers by Freimut H. Schilling

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Freimut H. Schilling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Freimut H. Schilling. The network helps show where Freimut H. Schilling may publish in the future.

Co-authorship network of co-authors of Freimut H. Schilling

This figure shows the co-authorship network connecting the top 25 collaborators of Freimut H. Schilling. A scholar is included among the top collaborators of Freimut H. Schilling based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Freimut H. Schilling. Freimut H. Schilling is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Health‐Related Quality of Life in Adult Patients With von Willebrand Disease From Germany: Results of the WIL‐QoL Study 2025 ·Haemophilia ·Sylvia von Mackensen, (unknown), Ronald Fischer, Susan Halimeh, Christine Heller, Wolfgang Miesbach, Freimut H. Schilling, C. Wermes, G. Auerswald, (unknown)	0
2	Acute and long-term psychosocial consequences in grandparents when a grandchild is diagnosed with cancer – the GROKids Project: a population-based mixed-methods study protocol 2023 ·BMC Psychology ·Gisela Michel, Peter Francis Raguindin, (unknown), (unknown), (unknown), Katrin Scheinemann, (unknown), Nicolas von der Weid, Pierluigi Brazzola, Jochen Roessler, Marc Ansari, Manuel Diezi, Maja Beck‐Popovic, Freimut H. Schilling, Jeanette Greiner, Heinz Hengartner	1
3	Systematic review: Care provided by grandparents of children with a chronic disease or a disability 2023 ·SHILAP Revista de lepidopterología ·(unknown), (unknown), Freimut H. Schilling, Gisela Michel, Katharina Roser	1
4	A Novel GATA1 Variant in the C-Terminal Zinc Finger Compared with the Platelet Phenotype of Patients with A Likely Pathogenic Variant in the N-Terminal Zinc Finger 2022 ·Cells ·José María Bastida, (unknown), (unknown), Verónica Palma‐Barqueros, (unknown), Marı́a Luisa Lozano, (unknown), Rocío Benito, Carlo Zaninetti, (unknown), Freimut H. Schilling, Neil V. Morgan, Kathleen Freson, José Rivera, Barbara Zieger	6
5	Cancer predisposition syndromes as a risk factor for early second primary neoplasms after childhood cancer – A national cohort study 2021 ·European Journal of Cancer ·Nicolas Waespe, Fabiën N. Belle, (unknown), Christina Schindera, Ben D. Spycher, Jochen Rößler, Marc Ansari, Claudia E. Kuehni, Maja Beck‐Popovic, Jean‐Pierre Bourquin, Pierluigi Brazzola, Jeanette Greiner, Katrin Scheinemann, Freimut H. Schilling, Nicolas von der Weid	13
6	Neuroblastoma Screening at 1 Year of Age: The Final Results of a Controlled Trial 2021 ·JNCI Cancer Spectrum ·Frank Berthold, Claudia Spix, R. Erttmann, Barbara Hero, J. Michaelis, J. Treuner, Angela Ernst, Freimut H. Schilling	6
7	Clinical and molecular characterization of patients with stage 4(M) neuroblastoma aged less than 18 months without MYCN amplification 2021 ·Pediatric Blood & Cancer ·Frank Berthold, Carolina Rosswog, Holger Christiansen, Michael C. Frühwald, (unknown), Thomas Klingebiel, Birgit Fröhlich, Freimut H. Schilling, Irene Schmid, Thorsten Simon, Barbara Hero, Matthias Fischer, Angela Ernst	4
8	Long-term outcomes of the GPOH NB97 trial for children with high-risk neuroblastoma comparing high-dose chemotherapy with autologous stem cell transplantation and oral chemotherapy as consolidation 2018 ·British Journal of Cancer ·Frank Berthold, Angela Ernst, Barbara Hero, Thomas Klingebiel, Bernhard Kremens, Freimut H. Schilling, Thorsten Simon	27
9	Building a National Framework for Adolescent and Young Adult Hematology and Oncology and Transition from Pediatric to Adult Care: Report of the Inaugural Meeting of the “AjET” Working Group of the German Society for Pediatric Oncology and Hematology 2016 ·Journal of Adolescent and Young Adult Oncology ·Gabriele Escherich, Stefan Bielack, Stephan E. Maier, (unknown), Tim H. Brümmendorf, Mathias Freund, Regine Grosse, (unknown), (unknown), Barbara Koch, Melchior Lauten, Valeria Milani, (unknown), Freimut H. Schilling, Dieter Wöhrle, Holger Cario, Uta Dirksen	11
10	Short‐ and long‐term outcome of patients with symptoms of spinal cord compression by neuroblastoma 2012 ·Developmental Medicine & Child Neurology ·Thorsten Simon, (unknown), Barbara Hero, (unknown), Meinolf Suttorp, Freimut H. Schilling, Frank Berthold	31
11	Low aerobic mitochondrial energy metabolism in poorly- or undifferentiated neuroblastoma 2010 ·BMC Cancer ·René G. Feichtinger, Franz Zimmermann, Johannes A. Mayr, Daniel Neureiter, Cornelia Hauser‐Kronberger, Freimut H. Schilling, Neil D. Jones, Wolfgang Sperl, Barbara Kofler	59
12	Towards shared patient records: An architecture for using routine data for nationwide research 2005 ·International Journal of Medical Informatics ·Petra Knaup, Sebastian Garde, (unknown), Norbert Graf, Freimut H. Schilling, R. Weber, Reinhold Haux	20
13	Galanin and galanin receptors in human cancers 2005 ·Neuropeptides ·Alexandra Berger, Radmila Santic, Cornelia Hauser‐Kronberger, Freimut H. Schilling, Per Kogner, Manfred Ratschek, (unknown), Neil D. Jones, Wolfgang Sperl, Barbara Kofler	42
14	Lead‐time and overdiagnosis estimation in neuroblastoma screening 2003 ·Statistics in Medicine ·Claudia Spix, J. Michaelis, Frank Berthold, R. Erttmann, Johannes Sander, Freimut H. Schilling	7
15	Efficiency and safety of chemotherapy plans for children: CATIPO—a nationwide approach 2002 ·Artificial Intelligence in Medicine ·Petra Knaup, (unknown), (unknown), Ursula Creutzig, Reinhold Haux, Freimut H. Schilling	15
16	Evidence of chromaffin oxygen sensing in neuroblastoma 2001 ·Medical and Pediatric Oncology ·F Hedborg, (unknown), (unknown), Lars Grimelius, Erik Wassberg, Barbara Hero, Freimut H. Schilling, Frank Berthold, D. Harms, Bengt Sandstedt	3
17	Combined111In-pentetreotide scintigraphy and123I-mIBG scintigraphy in neuroblastoma provides prognostic information 2000 ·Medical and Pediatric Oncology ·Freimut H. Schilling, H. Bihl, Hans Jacobsson, Peter F. Ambros, Tommy Martinsson, (unknown), K. Schwarz, Inge M. Ambros, J. Treuner, Per Kogner	35
18	Population-based and controlled study to evaluate neuroblastoma screening at one year of age in Germany: Interim results 2000 ·Medical and Pediatric Oncology ·Freimut H. Schilling, Frank Berthold, R. Erttmann, (unknown), Claudia Spix, (unknown), K. Schwarz, J. Treuner	7
19	Coexpression of mRNA for the full-length neurotrophin receptor trk-C and trk-A in favourable neuroblastoma 1997 ·European Journal of Cancer ·T.H. Svensson, Mikael Rydén, Freimut H. Schilling, C Dominici, Ravinder N. M. Sehgal, Carlos F. Ibáñez, Per Kogner	25
20	Neuroblastom-Früherkennung in Deutschland 1992 ·Klinische Pädiatrie ·Freimut H. Schilling, R. Erttmann, (unknown), Nicola Erb, K. Winkler, Uwe Groß, J. Treuner	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact